Finance

Lists
L020:FRA
Britannia Life Sciences Inc
€0.029
+1.75%
(+0.00050) 1D
Sep 3, 8:01:02 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for L020...
Open
€0.03
High
€0.03
Low
€0.03
Mkt. cap
12.31M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.07
52-wk low
€0.02
No. of employees
28
Open
€0.03
High
€0.03
Low
€0.03
Mkt. cap
12.31M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.07
52-wk low
€0.02
No. of employees
28
About Britannia Life Sciences Inc
CEO-
Employees28
Founded2000
Headquarters-
SectorService
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
111.87K
65.36K
127.84K
101.37K
Cost of goods sold
73.34K
29.44K
128.93K
81.94K
Cost of revenue
73.34K
29.44K
128.93K
81.94K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
720.52K
399.98K
177.00
377.78K
Operating expense
736.35K
415.70K
15.85K
377.78K
Total operating expenses
809.68K
445.14K
144.77K
459.72K
Operating income
-697.82K
-379.78K
-16.94K
-358.35K
Other non operating income
-
-
-66.34K
-
EBT including unusual items
-411.28K
12.51M
2.17M
1.20M
EBT excluding unusual items
-526.26K
-155.36K
428.09K
148.35K
Income tax expense
-
1.67M
-1.17M
-
Effective tax rate
-
13.38%
-53.69%
-
Other operating expenses
-
-
-
-
Net income
-411.28K
12.13M
3.63M
1.20M
Net profit margin
-367.65%
18,555.35%
2,835.86%
1,182.14%
Earnings per share
-
-
-
-
Interest and investment income
99.32K
311.64K
308.22K
355.00K
Interest expense
-6.68K
-5.76K
-4.92K
-4.30K
Net interest expenses
92.63K
305.88K
303.30K
350.70K
Depreciation and amortization charges
15.83K
15.72K
15.67K
-
EBITDA
-681.99K
-364.06K
-1.27K
-342.59K
Gain or loss from assets sale
-58.73K
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps